“Venom: The Last Dance” is two-stepping slower than its series predecessors in North America, after chowing down on $22 million from 4,131 domestic theaters across Friday and previews. That’s well below the first-day debuts of both the first “Venom” in 2018 ($32 million) and its 2021 sequel “Let There Be Carnage” ($37 million). It also puts Columbia Pictures’ trilogy capper on pace to land behind its projections, which had forecast an opening weekend in the neighborhood of $65 million.
That’s a definite downtrend for the franchise stateside, though “The Last Dance,” co-financed by TSG, is still tracking for the biggest domestic opening weekend since “Beetlejuice Beetlejuice” dominated in September.
→ Continue reading at Variety
